Search Results - "Modeste ES"

Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis.

Authors: Trautwig, Adam N. Fox, Edward J. Dammer, Eric B. et al.

Source: Molecular Neurodegeneration. 5/15/2025, Vol. 20 Issue 1, p1-18. 18p.

Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia.

Authors: Hok-A-Hin, Yanaika S. Vermunt, Lisa Peeters, Carel F.W. et al.

Source: Molecular Neurodegeneration. 8/27/2025, Vol. 20 Issue 1, p1-17. 17p.

Bridging the Gap: Multi-Omics Profiling of Brain Tissue in Alzheimer's Disease and Older Controls in Multi-Ethnic Populations.

Authors: Reddy JS Heath L Vander Linden A et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 20. Date of Electronic Publication: 2024 Apr 20.

Publication Type: Preprint; Journal Article

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Immune status assessment based on plasma proteomics with meta graph convolutional networks.

Authors: Zhang, Min Xu, Nan Cheng, Qi et al.

Source: BMC Genomics. 4/10/2025, Vol. 26 Issue 1, p1-17. 17p.

Persistent PirB cleavage drives Golgi-directed trafficking deficits underlying neurodegeneration.

Authors: Han WB Liu XD Tang CF et al.

Source: Translational neurodegeneration [Transl Neurodegener] 2026 Jun 03; Vol. 15 (1). Date of Electronic Publication: 2026 Jun 03.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101591861 Publication Model: Electronic Cited Medium: Print ISSN: 2047-9158 (Print) Linking ISSN: 20479158 NLM ISO Abbreviation: Transl Neurodegener Subsets: MEDLINE

Glymphatic system clearance and Alzheimer's disease risk: a CSF proteome-wide study.

Authors: Cullell, Natalia Caruana, Giovanni Elias-Mas, Andrea et al.

Source: Alzheimer's Research & Therapy. 1/31/2025, Vol. 17 Issue 1, p1-13. 13p.

Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.

Authors: Zeng, Xuemei Lafferty, Tara K. Sehrawat, Anuradha et al.

Source: Molecular Neurodegeneration. 10/10/2024, Vol. 19 Issue 1, p1-21. 21p.

Proteomic landscape of Alzheimer's disease: emerging technologies, advances and insights (2021 – 2025).

Authors: Yarbro, Jay M. Shrestha, Him K. Wang, Zhen et al.

Source: Molecular Neurodegeneration. 7/14/2025, Vol. 20 Issue 1, p1-17. 17p.

Biomarker identification for Alzheimer's disease through integration of comprehensive Mendelian randomization and proteomics data.

Authors: Zhan, Hui Cammann, Davis Cummings, Jeffrey L. et al.

Source: Journal of Translational Medicine. 3/6/2025, Vol. 23 Issue 1, p1-16. 16p.

Serum proteomics reveals early biomarkers of Alzheimer's disease: The dual role of APOE-ε4.

Authors: Ya-nan Ma Ying Xia Kenji Karako et al.

Source: BioScience Trends. Feb2025, Vol. 19 Issue 1, p1-9. 9p.

Platelet proteomic signatures of amyloid β-positive mild cognitive impairment and Alzheimer's disease.

Authors: Cho YE Kim A Lee HM et al.

Source: Molecular brain [Mol Brain] 2026 Mar 28; Vol. 19 (1). Date of Electronic Publication: 2026 Mar 28.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101468876 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-6606 (Electronic) Linking ISSN: 17566606 NLM ISO Abbreviation: Mol Brain Subsets: MEDLINE

Shake and bake: a robust and cost-effective proteomic sample preparation workflow for plasma and cerebrospinal fluid.

Authors: Rönnholm J Weiner S Fuchs J et al.

Source: Clinical proteomics [Clin Proteomics] 2026 Feb 15; Vol. 23 (1). Date of Electronic Publication: 2026 Feb 15.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101184586 Publication Model: Electronic Cited Medium: Print ISSN: 1542-6416 (Print) Linking ISSN: 15426416 NLM ISO Abbreviation: Clin Proteomics Subsets: PubMed not MEDLINE

Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease.

Authors: Guo, Qi Ping, Lingyan Dammer, Eric B. et al.

Source: Molecular Neurodegeneration. 10/25/2024, Vol. 19 Issue 1, p1-30. 30p.

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease.

Authors: Shantaraman, Anantharaman Dammer, Eric B. Ugochukwu, Obiadada et al.

Source: Molecular Neurodegeneration. 10/11/2024, Vol. 19 Issue 1, p1-24. 24p.

Proteins Associated with Cognition in Amyloid-beta Positive Elders Based on Cerebrospinal Fluid Proteomics.

Authors: Liu M Hu HY Fu Y et al.

Source: Molecular neurobiology [Mol Neurobiol] 2025 Dec 26; Vol. 63 (1), pp. 327. Date of Electronic Publication: 2025 Dec 26.

Publication Type: Journal Article

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE

CSF Glucose-6-Phosphate Isomerase Is a Tau-Related Biomarker Associated with Neurodegeneration and Cognitive Impairment in Alzheimer's Disease.

Authors: Chen Y Wang Z Chen H et al.

Corporate Authors: Chen Y Wang Z Chen H et al.

Source: Molecular neurobiology [Mol Neurobiol] 2025 Nov 15; Vol. 63 (1), pp. 47. Date of Electronic Publication: 2025 Nov 15.

Publication Type: Journal Article

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE

Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects.

Authors: Hidese, Shinsuke^1,2 (AUTHOR) hidese.shinsuke.xu@teikyo‐u.ac.jp

Source: Neuropsychopharmacology Reports. Jun2024, Vol. 44 Issue 2, p314-320. 7p.

Proximity extension assay-based proteomic studies in Alzheimer's disease.

Authors: Yaka, Emiş Cansu Genç, Şermin

Source: Turkish Journal of Neurology / Türk Nöroloji Dergisi. 2024, Vol. 30 Issue 2, p69-75. 7p.

Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.

Authors: Modeste, Erica S. Ping, Lingyan Watson, Caroline M. et al.

Source: Molecular Neurodegeneration. 7/19/2023, Vol. 18 Issue 1, p1-19. 19p.

Large-scale proteomic analyses of incident Alzheimer's disease reveal new pathophysiological insights and potential therapeutic targets.

Authors: Zhang Y Guo Y He Y et al.

Source: Molecular psychiatry [Mol Psychiatry] 2025 Jun; Vol. 30 (6), pp. 2347-2361. Date of Electronic Publication: 2024 Nov 19.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE